Skip to main content
. 2019 Dec 14;8(12):2212. doi: 10.3390/jcm8122212

Table 1.

Descriptive statistics for cohort and stratified by treatment group.

All Patients
N = 434
PAP
N = 325
Control
N = 109
p-Value
Age, years 51.9 ± 13.4 53.0 ± 13.0 48.9 ± 14.0 0.008
Female 219 (50.5%) 154 (47.4%) 65 (59.6%) 0.035
Caucasian 337 (77.6%) 258 (79.4%) 79 (72.5%) 0.087
Married 242 (55.8%) 190 (58.5%) 52 (47.7%) 0.170
Median income (×$1000) 53.3 ± 17.5 53.9 ± 17.6 51.6 ± 17.3 0.244
Smoking status
 Current 48 (11.1%) 34 (10.5%) 14 (12.8%) 0.473
 Former 142 (32.7%) 111 (34.2%) 31 (28.4%)
 Never 193 (44.5%) 142 (43.7%) 51 (46.8%)
 Missing 51 (11.8%) 38 (11.7%) 13 (11.9%)
Coronary artery disease 32 (7.4%) 24 (7.4%) 8 (7.3%) 1.000
Cancer 76 (17.5%) 55 (16.9%) 21 (19.3%) 0.563
Chronic renal failure 15 (3.5%) 10 (3.1%) 5 (4.6%) 0.544
Depression 116 (26.7%) 81 (24.9%) 35 (32.1%) 0.169
Diabetes 98 (22.6%) 68 (20.9%) 30 (27.5%) 0.185
Hypertension 168 (38.7%) 124 (38.2%) 44 (40.4%) 0.733
Stroke 15 (3.5%) 8 (2.5%) 7 (6.4%) 0.067
AHI 20 (9,44) 22 (11,49) 13 (8,32) <0.001
BMI, kg/m2 33 (28,38) 33 (29,38) 33 (27,39) 0.389
Neck circumference, cm 40 (37, 43.25) 40 (38, 43.5) 39.5 (36,43) 0.101
Family history of RLS 48 (11.1%) 35 (10.8%) 13 (11.9%) 0.726
RLS medications 202 (46.5%) 146 (44.9%) 56 (51.4%) 0.268
Exacerbating medications 198 (45.6%) 146 (44.9%) 52 (47.7%) 0.657
Any caffeine consumption 325 (74.9%) 252 (77.5%) 73 (67.0%) 0.054
Days from baseline to PSG 23.5 (6,41) 23 (7,38) 25 (5,44) 0.879
Days from PSG to follow-up 113 (75,169) 125 (86,172) 71 (42,131) <0.001
Baseline IRLS Score 16.2 ± 8.3 16.3 ± 8.3 15.9 ± 8.2 0.596
Baseline average sleep time
 <7 h 286 (65.9%) 216 (66.5%) 70 (64.2%) 0.615
 7–9 h 112 (25.8%) 83 (25.5%) 29 (26.6%)
 >9 h 27 (6.2%) 19 (5.8%) 8 (7.3%)

Statistics presented as Mean ± SD, Median [P25,P75], or N(column%). PAP: positive airway pressure; RLS: restless leg syndrome; SD: standard deviation; IQR: interquartile range; IRLS: International Restless Leg Syndrome Scale; ESS: Epworth Sleepiness Scale; PHQ-9: Patient Health Questionnaire; PSG: polysomnography.